Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018
Fri, March 9, 2018

Debjit Chattopadhyay Maintained (SRPT) at Strong Buy with Increased Target to $92 on, Mar 12th, 2018

Debjit Chattopadhyay of HC Wainwright & Co., Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $75 to $92 on, Mar 12th, 2018.

Debjit has made no other calls on SRPT in the last 4 months.



There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 0 agree with Debjit's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Debjit


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $64 on, Tuesday, March 6th, 2018
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $75 on, Wednesday, February 21st, 2018
  • Yun Zhong of "Janney Montgomery Scott" Initiated at Strong Buy and Held Target at $75 on, Thursday, January 4th, 2018